Xu, Aiqi
Li, Xi
Cai, Qiaoting
Yang, Ciqiu
Yang, Mei
Gao, Hongfei
Cheng, Minyi
Chen, Xianzhe
Ji, Fei
Tang, Hailin
Wang, Kun
Funding for this research was provided by:
Guangzhou Health Science and Technology Project (20241A011005)
National Natural Science Foundation of China (82171898)
Deng Feng project of high-level hospital construction (DFJHBF202109)
Guangdong Basic and Applied Basic Research Foundation (2023A1515010222, 2022A1515012277)
Guangzhou Science and Technology Project (202002030236)
Macao Science and Technology Development Fund (20210701181316106/AKP)
Beijing Medical Award Foundation (YXJL-2020-0941-0758)
Beijing Science and Technology Innovation Medical Development Foundation (KC2022-ZZ-0091-5)
Development Cancer for Medical Science and Technology National Health Commission of the People’s Republic of China (WKZX2023CX110002)
Beijing Life Oasis Public Service Center (cphcf-2022-058)
Article History
Received: 28 March 2024
Accepted: 12 August 2024
First Online: 23 August 2024
Declarations
:
: The authors declare no competing interests.
: All Breast cancer tissues and matched para-tumor tissues were in accordance with the ethical guidelines of Department of Breast Oncology, Guangdong Provincial People's Hospital. Each patient signed an ethics consent form before the study. All patients agreed to allow their sample data to be used for experimental studies and paper presentations (Ethics No.KY-Z-2021-061-02).